Mallinckrodt to Present at Jefferies London Healthcare Conference
Mallinckrodt plc has announced its participation in the upcoming Jefferies London Healthcare Conference. Siggi Olafsson, President and Chief Executive Officer, will deliver a presentation on Tuesday, November 19, 2024, at 9:30 a.m. GMT/4:30 a.m. ET. For those unable to attend in person, a webcast will be available online, with a replay option provided after the event.
Mallinckrodt plc ha annunciato la sua partecipazione alla prossima Jefferies London Healthcare Conference. Siggi Olafsson, Presidente e Amministratore Delegato, presenterà martedì 19 novembre 2024, alle 9:30 GMT/4:30 ET. Per coloro che non possono partecipare di persona, sarà disponibile una trasmissione in diretta online, con un'opzione di riproduzione successiva all'evento.
Mallinckrodt plc ha anunciado su participación en la próxima Jefferies London Healthcare Conference. Siggi Olafsson, Presidente y Director Ejecutivo, dará una presentación el martes 19 de noviembre de 2024, a las 9:30 a.m. GMT/4:30 a.m. ET. Para aquellos que no puedan asistir en persona, habrá un webcast disponible en línea, con la opción de repetición después del evento.
몰링크로드 plc는 다가오는 제퍼리즈 런던 헬스케어 컨퍼런스 참여를 발표했습니다. Siggi Olafsson 사장 겸 CEO가 2024년 11월 19일 화요일 GMT 오전 9시 30분/ET 오전 4시 30분에 발표를 진행할 예정입니다. 현장에 참석할 수 없는 분들을 위해, 웹캐스트가 온라인에서 제공되며, 이벤트 이후 재생 옵션도 제공됩니다.
Mallinckrodt plc a annoncé sa participation à la prochaine Jefferies London Healthcare Conference. Siggi Olafsson, Président et Directeur Général, présentera le mardi 19 novembre 2024, à 9h30 GMT/4h30 ET. Pour ceux qui ne peuvent pas assister en personne, un webcast sera disponible en ligne, avec une option de rediffusion après l'événement.
Mallinckrodt plc hat seine Teilnahme an der bevorstehenden Jefferies London Healthcare Conference angekündigt. Siggi Olafsson, Präsident und Geschäftsführer, wird am Dienstag, dem 19. November 2024, um 9:30 Uhr GMT/4:30 Uhr ET eine Präsentation halten. Für diejenigen, die nicht persönlich teilnehmen können, wird ein Webcast online zur Verfügung stehen, mit einer Wiederholungsoption nach der Veranstaltung.
- None.
- None.
Individuals who cannot attend the meeting in person can find webcast information at:https://wsw.com/webcast/jeff315/mnk/1699320. A replay will also be available following the meeting.
ABOUT MALLINCKRODT
Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. The Company's Specialty Brands reportable segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; and gastrointestinal products. Its Specialty Generics reportable segment includes specialty generic drugs and active pharmaceutical ingredients. To learn more about Mallinckrodt, visit www.mallinckrodt.com.
Mallinckrodt uses its website as a channel of distribution of important company information, such as press releases, investor presentations and other financial information. It also uses its website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the SEC disclosing the same information. Therefore, investors should look to the Investor Relations page of the website for important and time-critical information. Visitors to the website can also register to receive automatic e-mail and other notifications alerting them when new information is made available on the Investor Relations page of the website.
CONTACTS
Investor Relations
Derek Belz
Vice President, Investor Relations
314-654-3950
derek.belz@mnk.com
Media
Michael Freitag / Aaron Palash / Aura Reinhard / Catherine Simon
Joele Frank, Wilkinson Brimmer Katcher
212-355-4449
Mallinckrodt, the "M" brand mark and the Mallinckrodt Pharmaceuticals logo are trademarks of a Mallinckrodt company. Other brands are trademarks of a Mallinckrodt company or their respective owners. © 2024.
View original content to download multimedia:https://www.prnewswire.com/news-releases/mallinckrodt-to-present-at-jefferies-london-healthcare-conference-302305741.html
SOURCE Mallinckrodt plc
FAQ
When is Mallinckrodt (MNK) presenting at the Jefferies London Healthcare Conference 2024?
How can I watch Mallinckrodt's (MNK) presentation at the Jefferies Conference?
Who will represent Mallinckrodt (MNK) at the 2024 Jefferies London Healthcare Conference?
